Matches in Nanopublications for { ?s ?p "[High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- assertion description "[High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP389307.RAcJcLytmDAihOsiuLkvT8sTXSv-oYbXDJxSfPUMRzG9c130_assertion description "[High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389307.RAcJcLytmDAihOsiuLkvT8sTXSv-oYbXDJxSfPUMRzG9c130_provenance.
- NP389298.RAAVjYt_8v0AocJgF2vRUN3STruy2sMLuyFzRPiDcnwEc130_assertion description "[High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389298.RAAVjYt_8v0AocJgF2vRUN3STruy2sMLuyFzRPiDcnwEc130_provenance.
- NP389300.RAuq-nKVpSLIvL7MOvAwo16wToDqJbV_vNutcyek9NTbc130_assertion description "[High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389300.RAuq-nKVpSLIvL7MOvAwo16wToDqJbV_vNutcyek9NTbc130_provenance.
- NP389297.RAw2adE2oU0YMCZKIn5p4Op5ukP8pM4hAIRRvlKazeP7Q130_assertion description "[High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389297.RAw2adE2oU0YMCZKIn5p4Op5ukP8pM4hAIRRvlKazeP7Q130_provenance.
- NP389301.RA6JPyU2Hv6WVj3iOmuwaWziTNPgBQ0yz5J4GdatB_z2k130_assertion description "[High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389301.RA6JPyU2Hv6WVj3iOmuwaWziTNPgBQ0yz5J4GdatB_z2k130_provenance.
- NP389302.RA0I8P-2QfXYwCp7TSg4pYYIoZiNCuki_ig99BDi67FXY130_assertion description "[High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389302.RA0I8P-2QfXYwCp7TSg4pYYIoZiNCuki_ig99BDi67FXY130_provenance.
- NP389303.RA3tEsxMkuYEAqQv4uqxEHWF0y2zxM6okW3ycE75rslBU130_assertion description "[High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389303.RA3tEsxMkuYEAqQv4uqxEHWF0y2zxM6okW3ycE75rslBU130_provenance.
- NP389306.RA2hmD9NE_nbaFot2T28DBnCQwt-Sy13lshkoh5YwVZbk130_assertion description "[High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389306.RA2hmD9NE_nbaFot2T28DBnCQwt-Sy13lshkoh5YwVZbk130_provenance.